{
  "alternativeShortCodes": ["ApoB"],
  "displayName": "ApoB",
  "description": "ApoB is the best biomarker for assessing ASCVD risk, as it encompasses all atherogenic lipoprotein particles, including LDL, IDL, VLDL, and Lp(a).",
  "longName": "Apolipoprotein B",
  "unit": "mg/dL",
  "rangeSources": [
    {
      "source": {
        "name": "Peter Attia",
        "url": "https://docs.google.com/document/d/1qw7BRXC-dX1Vmci0vijwYyxwdqxqhj4FMUXeMNQg2Rs"
      },
      "range": {
        "type": "generic",
        "min": null,
        "max": 65
      },
      "note": "62 mg/dL would be the top (best) 5% of the population.\n\n\"I just don't see a reason to have an ApoB ever north of 60 milligrams per deciliter.\" - Peter Attia.\n\nApoB between 20 to 30 mg/dL should eliminate ASCVD risk if other risk factors are eliminated as well (high blood pressure and smoking)."
    }
  ]
}
